Experiment 635423
Details
| Property | Value |
|---|---|
| Pharmacology | |
| Administration route | ORAL |
| Organism | Tanacetum parthenium (ASTERACEAE) |
| Citation | VOGLER,BK: PITTLER,MH: ERNST,E:. (1998). FEVERFEW AS A PREVENTIVE TREATMENT FOR MIGRAINE: A SYSTEMATIC REVIEW.. 18() |
| Amount utilized | |
| Compound isolated | |
| Disease | DOUBLE-BLIND PLACEBO-CONTROLLED ASSESSED THE EFFICACY OF FEVERFEW AS A PREVENTIVE TREATMENT FOR A MIGRAINE. 5 CLINICAL STUDIES WERE SELECTED. JOHNSON CT. A PILOT TRIAL INCLUDING 17 PATIENTS WHO HAD TAKEN RAW FEVERFEW LEAVES EVERY DAY FOR THE PREVIOUS 3-4 YEARS. PATIENTS RECEIVED TWO CAPSULES OF FREEZE-DRIED FEVERFEW LEAVES DAILY (50 MG) OR IDENTICAL PLACEBO FOR 24 WEEKS. THEY WERE ADVISED TO GRADE SEVERITY AND FREQUENCY OF HEADACHE, VISUAL DISTURBANCE, AND INCIDENCE OF NAUSEA AND VOMITING ON DIARY CARDS. THE RESULTS OF THIS TRIAL SHOWED A SIGNIFICANT INCREASE OF MEAN ATTACK FREQUENCY PER MONTH IN THE PLACEBO GROUP COMPARED TO BASELINE MEASUREMENTS (P<0.02), WHILE ATTACK FREQUENCY REMAINED CONSTANT IN PATIENTS RECEIVING FEVERFEW. IN ADDITION, PATIENTS ASSESSED THE OVERALL TREATMENT EFFECT ON A SIX-POINT SCALE. 5 OF 8 PATIENTS FROM THE FEVERFEW GROUP REPORTED GOOD TO EXCELLENT EFFECTIVENESS, WHILE THIS WAS REPORTED BY ONLY ONE PATIENT IN THE PLACEBO GROUP(P<0.01 |
| Dose amount | 100.0 MG |
| Number | 1 |
| Qualitative result | ACTIVE |
| Animal | HUMAN ADULT |
| Per unit | DAY |
| Dose expression | DOSE |
| Extract | LEAVES |
| Gender | GIVEN TO BOTH SEXES |